-transparent.png){kind=logo}
A technique is presented for study of steady state kinetics of methadone using pulse labeling with deuterated methadone (d3) and mass fragmentography to measure both unlabeled and labeled methadone in blood. Seven subjects maintained on methadone for at least 10 months were admitted to a closed metabolic ward. The daily dose of unlabeled methadone (d0) was substituted by one dose of methoadone-d3 and plasma levels of methadone-d0 and methadone-d3 were followed for 48 h using a precise (SD +/- 5%) and sensitive (30 pmol/ml) mass fragmentographic technique. Plasma half-lives (T1/2) for both methadone-do and methadone-d3 were calculated from samples obtained 8--24 H following the dose of methadone-d3. The t1/2 of oral methadone-d3 was shorter (22 +/- 2 h) than that of methadone-d0 (52 +/- 20 h). The same pattern was observed after intravenous administration. The results indicate multiple pools of methadone in the body.
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
November 2000,
British journal of clinical pharmacology,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
January 1977,
Proceedings of the Western Pharmacology Society,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
January 1993,
European journal of clinical pharmacology,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
May 2007,
Journal of clinical pharmacology,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
January 1983,
Clinical and experimental neurology,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
January 2015,
Antimicrobial agents and chemotherapy,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
April 1998,
Pharmacy world & science : PWS,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
June 1987,
JAMA,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
November 1990,
Journal of clinical pharmacology,
E Anggård, and
M I Nilsson, and
J Holmstrand, and
L M Gunne
January 2007,
Antimicrobial agents and chemotherapy,
